Lineage Cell Therapeutics, Inc. (LCTX): Operating Income
-$36.62M
Year ended 2025-12-31
-$26.85M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$36.62M | n/m | 2026-03-05, From 2025-01-01 |
| 2024-12-31 | -$21.48M | n/m | 2026-03-05, From 2024-01-01 |
| 2023-12-31 | -$24.73M | n/m | 2025-03-10, From 2023-01-01 |
| 2022-12-31 | -$22.52M | n/m | 2024-03-07, From 2022-01-01 |
| 2021-12-31 | -$49.21M | n/m | 2023-03-09, From 2021-01-01 |
| 2020-12-31 | -$26.45M | n/m | 2022-03-10, From 2020-01-01 |
| 2019-12-31 | -$38.88M | n/m | 2021-03-11, From 2019-01-01 |
| 2018-12-31 | -$41.80M | n/m | 2020-03-12, From 2018-01-01 |
| 2017-12-31 | -$38.90M | n/m | 2019-03-14, From 2017-01-01 |
| 2016-12-31 | -$58.97M | n/m | 2018-03-15, From 2016-01-01 |
| 2015-12-31 | -$65.81M | n/m | 2018-03-15, From 2015-01-01 |
| 2014-12-31 | -$50.68M | n/m | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | -$55.99M | n/m | 2016-03-15, From 2013-01-01 |
| 2012-12-31 | -$25.00M | n/m | 2015-03-11, From 2012-01-01 |
| 2011-12-31 | -$18.69M | n/m | 2014-03-17, From 2011-01-01 |
| 2010-12-31 | -$9.85M | n/m | 2013-03-18, From 2010-01-01 |
| 2009-12-31 | -$3.52M | n/a | 2012-03-14, From 2009-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Lineage Cell Therapeutics, Inc. (LCTX) | 2025-12-31 | -$36.62M | n/m |
| Relay Therapeutics, Inc. (RLAY) | 2025-12-31 | -$302.74M | n/m |
| Pelthos Therapeutics Inc. (PTHS) | 2025-12-31 | -$32.43M | n/m |
| Caribou Biosciences, Inc. (CRBU) | 2025-12-31 | -$148.34M | n/m |
| LENZ Therapeutics, Inc. (LENZ) | 2025-12-31 | -$91.14M | n/m |
| TScan Therapeutics, Inc. (TCRX) | 2025-12-31 | -$135.81M | n/m |
| Alpha Cognition Inc. (ACOG) | 2025-12-31 | -$22.66M | n/m |
| Alector, Inc. (ALEC) | 2025-12-31 | -$156.01M | n/m |
| Taysha Gene Therapies, Inc. (TSHA) | 2025-12-31 | -$110.50M | n/m |
Compare LCTX, RLAY, PTHS, CRBU side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗